Net Cash Provided by (Used in) Operating Activities |
-435K |
USD |
-192% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
400M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
60.4M |
shares |
-15.5% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-436K |
USD |
-1369% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
520K |
USD |
-77% |
Q3 2024 |
Q3 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
1.06M |
USD |
+1.53% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
2.12M |
USD |
+1.53% |
Q4 2023 |
FY 2023 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-1.5M |
USD |
-355% |
Q3 2024 |
Q3 2024 |
Additional Paid in Capital |
28.1M |
USD |
-1.42% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
1.06M |
USD |
+1.53% |
Q4 2023 |
FY 2023 |
Share-based Payment Arrangement, Expense |
0 |
USD |
|
Q1 2024 |
Q1 2024 |